化合物HM03 T8668
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 500565-15-1 | ¥662.00 | 询底价 |
25 mg | 500565-15-1 | ¥1,320.00 | 询底价 |
200 mg | 500565-15-1 | ¥4,960.00 | 询底价 |
1 mg | 500565-15-1 | ¥186.00 | 询底价 |
500 mg | 500565-15-1 | ¥7,560.00 | 询底价 |
1 mL | 500565-15-1 | ¥455.00 | 询底价 |
100 mg | 500565-15-1 | ¥3,480.00 | 询底价 |
2 mg | 500565-15-1 | ¥258.00 | 询底价 |
5 mg | 500565-15-1 | ¥413.00 | 询底价 |
50 mg | 500565-15-1 | ¥2,150.00 | 询底价 |
Product Introduction
Bioactivity
英文名: HM03
描述: HM03 是一种有效的选择性 HSPA5 抑制剂,具有抗癌活性。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 125 mg/mL (270.00 mM)
关键字: shock | inhibit | heat | tumor | HM 03 | cancer | cell | HM03 | protein | Heat shock proteins | HSP | HM-03 | Inhibitor | HCT116
相关产品: PU-H71 | HSP90-IN-27 | TRC051384 | VER49009 | Ganetespib | HSP70/SIRT2-IN-2 | DN401 | Palmitic acid | SNX0723 | Alvespimycin
相关库: Anti-Breast Cancer Compound Library | Anti-Cancer Compound Library | Anti-Metabolism Disease Compound Library | Bioactive Compounds Library Max | Endoplasmic Reticulum Stress Compound Library | Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Cancer Active Compound Library | Metabolism Compound Library | Bioactive Compound Library
化合物HM03 T8668信息由TargetMol中国为您提供,如您想了解更多关于化合物HM03 T8668报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途